Last Updated: November 8, 2026

Details for New Drug Application (NDA): 020740

« Back to Dashboard

NDA 020740 describes BAYCOL, which is a drug marketed by Bayer Pharms and is included in one NDA. Additional details are available on the BAYCOL profile page.

The generic ingredient in BAYCOL is cerivastatin sodium. There is one drug master file entry for this compound. Additional details are available on the cerivastatin sodium profile page.

Summary for 020740

Tradename:	BAYCOL
Applicant:	Bayer Pharms
Ingredient:	cerivastatin sodium
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	0.05MG
Approval Date:	Jun 26, 1997	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	0.1MG
Approval Date:	Jun 26, 1997	TE:		RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	0.2MG
Approval Date:	Jun 26, 1997	TE:		RLD:	No

Expired US Patents for NDA 020740

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-005	May 24, 1999	⤷ Start Trial	⤷ Start Trial
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-002	Jun 26, 1997	⤷ Start Trial	⤷ Start Trial
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-004	Jun 26, 1997	⤷ Start Trial	⤷ Start Trial
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-006	Jul 24, 2000	⤷ Start Trial	⤷ Start Trial
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-001	Jun 26, 1997	⤷ Start Trial	⤷ Start Trial
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-005	May 24, 1999	⤷ Start Trial	⤷ Start Trial
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-003	Jun 26, 1997	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.